Avandia - MSN Newsfeeds
- Fort Wayne Journal Gazette - Researchers found no link to the diabetes drug rosiglitazone, trade-named Avandia, which previously has been linked to deaths from heart disease. Mastbaum and other doctors emphasized that the benefits of lowering blood sugar to currently recommended ...
- Bloomberg - Feb. 7 (Bloomberg) -- GlaxoSmithKline Plc, Europe's largest drugmaker, fell the most in almost six years in London trading after reporting a steeper decline in fourth-quarter profit than analysts estimated and saying earnings will drop this year ...
- eMaxHealth.com - For both the intensive and standard treatment groups, study clinicians could use all major classes of diabetes medications available: metformin, thiazolidinediones (TZDs, primarily rosiglitazone), insulins, sulfonylureas, exanatide, and acarbose. ...
- Medical News Today - Both intensive and standard groups were treated using a range of diabetes medications such as: thiazolidinediones (TZDs, primarily rosiglitazone), metformin, insulins, sulfonylureas, exanatide, and acarbose. One drug in particular was scrutinized ...
- Los Angeles Times - In particular, researchers did not find any link to the diabetes drug rosiglitazone, trade-named Avandia, which has previously been linked to deaths from heart disease among those taking it. Dr. William T. Friedewald of Columbia University, who led ...
- Reuters - GSK, Europe's biggest drugmaker, slumped 7.6 percent after it warned that 2008 earnings would fall due to sliding sales of diabetes drug Avandia and more generic competition. For details please double click on [ID:nL07669658] Rival AstraZeneca (AZN ...
- Medscape News - We know that rosiglitazone increases MI risk, so others may do this too." He said not enough data on rosiglitazone use in ACCORD had been released to establish whether it could have played a role in the adverse outcome. "We don't even know what ...
- Forbes - CHICAGO, (Reuters) - The popular diabetes drug Avandia did not cause higher rates of death in a study testing ways to prevent heart problems in high-risk diabetics, researchers said Wednesday, who instead blamed overly aggressive therapy. They said ...
- Pravda - The profound study showed that the cause of deaths was sudden drops of significant value in patient's blood sugar, but not the drug itself. Avandia or Rosiglitazone first attracted public attention in 2007 when Dr. Steven Nissen and his colleague ...
- Forbes - The medications used included metformin, thiazolidinediones (TZDs, primarily rosiglitazone), insulins, sulfonylureas, exanatide, and acarbose. Of the companies that provided medications, equipment, or supplies for the Accord study, GlaxoSmithKline ...
- Reuters - Concerns about the safety of Avandia, known generically as rosiglitazone, were triggered in May by a U.S. analysis linking it to a 43 percent higher risk of heart attack. "Because of the recent concerns with rosiglitazone, our extensive analysis ...
- CNN Money - In 2006 Avandia, whose generic name is rosiglitazone, was GlaxoSmithKline's second-best selling product with sales of GBP1.6 billion . Following the publication of an article in the New England Journal of Medicine in May 2007 , which pointed to an ...
- Reuters - Concerns about the safety of Avandia, known generically as rosiglitazone, were triggered in May by a U.S. analysis linking it to a 43 percent higher risk of heart attack. "Because of the recent concerns with rosiglitazone, our extensive analysis ...
- Medscape News - The higher death rate in the intensive group was not due to episodes of hypoglycemia or to any single drug, including rosiglitazone , or to a combination of drugs, ACCORD investigators said. ACCORD is an National Heart, Lung, and Blood ...
- eMaxHealth.com - For both the intensive and standard treatment groups, study clinicians could use all major classes of diabetes medications available: metformin, thiazolidinediones (TZDs, primarily rosiglitazone), insulins, sulfonylureas, exanatide, and acarbose. ...
- Forbes - Long-term safety data is expected to become increasingly important following safety issues raised by recent meta-analyses of rosiglitazone over ischemic events. This will raise the safety bar for new products and is likely to lead to new classes ...
- Associated Press - A Texas doctor leaked confidential research to the makers of the popular diabetes drug Avandia weeks before a study was published tying the drug to higher heart risks, the scientific journal Nature reported Wednesday. Dr. Steven Haffner, of the ...
- Forbes - ... initial treatment with Lipitor to 2nd line, 3rd line; initial treatment with Zocor to 2nd line, 3rd line). -- Pathway to key therapies from previous therapies (e.g., how much Avandamet use is preceded by metformin, Avandia ...
- RTT News - ... legacy in the 2007 results presentation on Thursday, when he is expected to stress GlaxoSmithKline's strong pipeline of experimental medicines while preparing investors for a difficult period ahead as five products go off patent and sales of Avandia ...
- RTT News - ... legacy in the 2007 results presentation on Thursday, when he is expected to stress GlaxoSmithKline's strong pipeline of experimental medicines while preparing investors for a difficult period ahead as five products go off patent and sales of Avandia ...
Pages: Previous 1 2 3 4 5 6 7 8 9 ... Next






